Medicare Should Cover Wegovy — but Not Negotiate Its Price

Former Trump administration health official Joe Grogan applauds Biden proposal that Medicare and Medicaid cover GLP-1 weight loss drugs — but says subjecting Wegovy to price controls is a bad move.